Document is current

Any future updates will be listed below

Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism

Crossref DOI link: https://doi.org/10.1007/s12265-022-10302-4

Published Online: 2022-08-15

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark